A three day event discussing aspects of the innate immune system.
This year there are three main topics for discussion
The Innate Immunity Interactions with Pathogens
Interactions of the Innate and Adaptive Immune Systems
Therapeutic applications of the Innate Immune system
With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding an organisms first line of defense.
Who Should Attend: Academic and biotechnology/biopharma research professionals interested in function and potency of immune response components against pathogens and tumours; also scientists interested in how understa nding these mechanisms can inform the design of biological therapeutics and their mechanisms of action , with translational implications for therapy.
This event has an open poster session. Posters can be submitted on any subject related to Innate Immunity
This event has CPD accreditation.
The deadline for abstract submissions for oral presentation is July 10th 2014. Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at: www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
Program Outline
Day 1: Innate Immunity Interactions with Pathogens
Infectious disease are still a major cause of morbidity and mortality worldwide. Innate immunity is of paramount importance for the control of pathogens in the early stages of the infection and for the engenderment and expansion of acquired immunity. This will be a premier forum for the presentation of cutting-edge research on how the interaction between innate immune mechanisms and pathogens impacts on host resistance, immunoevasion, immunodeficiencies and vaccine efficacy, providing a deep insight into future research and more rational measures to prevent and treat infectious diseases of humans and animals. Session Chair: Dr Pietro Mastroeni, Cambridge University, UK
Day 2: Investigating interactions of the Innate and Adaptive Immune Systems
The cells of the innate immune system play a crucial part in immune defense against disease but also respond to the presence of malignant cells, initiating and subsequently directing adaptive immune responses. The session will discuss the roles of different components of the innate immune system, with focus on disease mechanisms and interactions between inflammatory cells, antibodies and pathogenic or tumour antigens and how these impact on disease progression. The session will draw on new cutting edge research and will provide ample opportunity for networking and informal discussions.
Session Chair: Dr Sophia N. Karagiannis, Senior Lecturer in Translational Cancer Immunology, Head of Cancer Antibody Discovery and Immunotherapy, St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London School of Medicine, UK
Day 3: Therapeutic applications of the Innate Immune system
The identification of antigen recognition receptors for innate immunity has sparked great interest in therapeutic manipulation of the innate immune system. For example Toll-like receptor agonists are being developed for the treatment of cancer, allergies and viral infections, and as adjuvants for cancer and disease vaccines. This session will explore current research and applications of the innate system for therapeutic applications. There will be plenty of opportunity for discussion and debate and we encourage submission of abstracts for both oral and poster presentation. Session Chair: To be confirmed
This year there are three main topics for discussion
The Innate Immunity Interactions with Pathogens
Interactions of the Innate and Adaptive Immune Systems
Therapeutic applications of the Innate Immune system
With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding an organisms first line of defense.
Who Should Attend: Academic and biotechnology/biopharma research professionals interested in function and potency of immune response components against pathogens and tumours; also scientists interested in how understa nding these mechanisms can inform the design of biological therapeutics and their mechanisms of action , with translational implications for therapy.
This event has an open poster session. Posters can be submitted on any subject related to Innate Immunity
This event has CPD accreditation.
The deadline for abstract submissions for oral presentation is July 10th 2014. Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at: www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
Program Outline
Day 1: Innate Immunity Interactions with Pathogens
Infectious disease are still a major cause of morbidity and mortality worldwide. Innate immunity is of paramount importance for the control of pathogens in the early stages of the infection and for the engenderment and expansion of acquired immunity. This will be a premier forum for the presentation of cutting-edge research on how the interaction between innate immune mechanisms and pathogens impacts on host resistance, immunoevasion, immunodeficiencies and vaccine efficacy, providing a deep insight into future research and more rational measures to prevent and treat infectious diseases of humans and animals. Session Chair: Dr Pietro Mastroeni, Cambridge University, UK
Day 2: Investigating interactions of the Innate and Adaptive Immune Systems
The cells of the innate immune system play a crucial part in immune defense against disease but also respond to the presence of malignant cells, initiating and subsequently directing adaptive immune responses. The session will discuss the roles of different components of the innate immune system, with focus on disease mechanisms and interactions between inflammatory cells, antibodies and pathogenic or tumour antigens and how these impact on disease progression. The session will draw on new cutting edge research and will provide ample opportunity for networking and informal discussions.
Session Chair: Dr Sophia N. Karagiannis, Senior Lecturer in Translational Cancer Immunology, Head of Cancer Antibody Discovery and Immunotherapy, St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London School of Medicine, UK
Day 3: Therapeutic applications of the Innate Immune system
The identification of antigen recognition receptors for innate immunity has sparked great interest in therapeutic manipulation of the innate immune system. For example Toll-like receptor agonists are being developed for the treatment of cancer, allergies and viral infections, and as adjuvants for cancer and disease vaccines. This session will explore current research and applications of the innate system for therapeutic applications. There will be plenty of opportunity for discussion and debate and we encourage submission of abstracts for both oral and poster presentation. Session Chair: To be confirmed
